Back to top
more

QuidelOrtho (QDEL)

(Delayed Data from NSDQ)

$68.74 USD

68.74
453,805

-0.48 (-0.69%)

Updated Dec 4, 2023 04:00 PM ET

After-Market: $68.77 +0.03 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.96%
2Buy17.61%
3Hold8.96%
4Sell4.80%
5Strong Sell2.32%
S&P50010.64%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 43% (144 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for QDEL

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for QuidelOrtho Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Assets          
Cash & Equivalents 345 829 490 53 44
Receivables 454 378 498 95 59
Notes Receivable 0 0 0 0 0
Inventories 524 199 114 58 67
Other Current Assets 252 35 41 17 24
Total Current Assets 1,575 1,440 1,142 222 193
Net Property & Equipment 1,339 349 110 80 74
Investments & Advances 21 38 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 16 20 45 25 22
Intangibles 5,601 436 459 485 512
Deposits & Other Assets 123 20 14 7 5
Total Assets 8,856 2,430 1,871 911 806
Liabilities & Shareholders Equity 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Notes Payable 0 0 0 13 54
Accounts Payable 283 101 86 27 25
Current Portion Long-Term Debt 208 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 139 40 35 17 19
Income Taxes Payable 52 67 128 0 0
Other Current Liabilities 325 105 80 63 61
Total Current Liabilities 1,007 324 337 126 160
Mortgages 0 0 0 0 0
Deferred Taxes/Income 213 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 2,431 0 0 0 53
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 84 49 101 132 168
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 3,921 501 538 351 381
Shareholders Equity 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 2,804 280 388 426 364
Retained Earnings 2,198 1,649 945 135 62
Other Equity -68 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 4,935 1,929 1,333 560 426
Total Liabilities & Shareholder's Equity 8,856 2,430 1,871 911 806
Total Common Equity 4,935 1,929 1,333 560 426
Shares Outstanding 66.00 41.60 42.00 41.60 39.30
Book Value Per Share 74.77 46.38 31.73 13.46 10.83

Fiscal Year End for QuidelOrtho Corporation falls in the month of December.

All items in Millions except Per Share data.

9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Assets          
Cash & Equivalents 193 224 397 345 264
Receivables 331 247 275 454 417
Notes Receivable 0 0 0 0 0
Inventories 552 542 529 524 536
Other Current Assets 295 296 299 252 228
Total Current Assets 1,371 1,308 1,499 1,575 1,445
Net Property & Equipment 1,369 1,376 1,362 1,339 1,262
Investments & Advances 12 25 34 21 20
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 16 16 17 16 19
Intangibles 5,419 5,507 5,570 5,601 5,582
Deposits & Other Assets 179 141 127 123 164
Total Assets 8,539 8,550 8,787 8,856 8,656
Liabilities & Shareholders Equity 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Notes Payable 0 0 0 0 0
Accounts Payable 253 226 242 283 242
Current Portion Long-Term Debt 193 207 208 208 208
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 107 82 109 139 116
Income Taxes Payable 2 2 16 52 67
Other Current Liabilities 305 273 334 325 241
Total Current Liabilities 860 790 908 1,007 873
Mortgages 0 0 0 0 0
Deferred Taxes/Income 197 200 209 213 256
Convertible Debt 0 0 0 0 0
Long-Term Debt 2,275 2,309 2,380 2,431 2,482
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 65 111 84 87
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 3,572 3,548 3,791 3,921 3,860
Shareholders Equity 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 2,839 2,825 2,809 2,804 2,772
Retained Earnings 2,181 2,194 2,247 2,198 2,168
Other Equity -53 -16 -59 -68 -145
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 4,967 5,003 4,997 4,935 4,795
Total Liabilities & Shareholder's Equity 8,539 8,550 8,787 8,856 8,656
Total Common Equity 4,967 5,003 4,997 4,935 4,795
Shares Outstanding 66.80 66.60 66.60 66.00 66.00
Book Value Per Share 74.35 75.11 75.02 74.77 72.66